Speech-Language Pathologists in Cleves, OH Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Mrs. Tricia Lynn Moehring, M.A.-CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 Cooper Ave, Cleves, OH 45002 Phone: 513-467-3500 |
Mrs. Deborah Williams, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 Cooper Ave, Cleves, OH 45002 Phone: 513-467-3210 |
Lisa Ann Duwell, MA,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 Cooper Ave, Cleves, OH 45002 Phone: 513-467-3210 |
Linda Lakamp, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 Cooper Ave, Cleves, OH 45002 Phone: 513-467-3200 |
Cayleigh Shank, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 Cooper Ave, Cleves, OH 45002 Phone: 513-467-3500 |
News Archive
Assumptions about liver transplant wait-list mortality challenged
The majority of liver patients who die on, or are removed from, the transplant wait-list have declined an offer of transplant, show the findings of an American study.
DIM compound derived from cruciferous vegetable protects rodents from radiation doses
Georgetown University Medical Center researchers say a compound derived from cruciferous vegetable such as cabbage, cauliflower and broccoli protected rats and mice from lethal doses of radiation.
Tumor necrosis factor may help control blood pressure, study suggests
Investigators at the Ted Rogers Centre for Heart Research have discovered a surprising new role for tumor necrosis factor (TNF): namely, that it is a major regulator of small blood vessel function, the key determinant of blood pressure. The study is published online today in Nature Communications.
Accelr8 and Novartis extend collaboration for BACcel system development
Accelr8 Technology Corporation announced that Accelr8 and Novartis have extended their program agreement through September 30, 2011. Having reviewed new data, Novartis will now install a system in their own facility to expand development capacity.
› Verified 8 days ago